comparemela.com

Page 16 - Gurnet Point News Today : Breaking News, Live Updates & Top Stories | Vimarsana

PureTech Appoints Sharon Barber-Lui to Board of Directors & Audit Committee

Press release content from Business Wire. The AP news staff was not involved in its creation.

United statesUnited kingdomGurnet pointBennett shapiroBen shapiroRob winderBharatt chowriraPaulc cabotBob langerAsia pacificChristopher viehbacherDame marjorie scardinoKiran mazumdar shawChris viehbacherBen atwellJohn lamattina

Innocoll Pharmaceuticals Limited: Innocoll Announces Positive Topline Results For XARACOLL (bupivacaine hydrochloride) implant in a Phase 3 Study to Support Expanded Use

XARACOLL 300mg Dose Cohort Experienced Less Pain and XARACOLL was Generally Well Tolerated with an Adverse Event Profile Comparable to the Current Prescribing Information Innocoll Pharmaceuticals

United kingdomKostenloser wertpapierhandelBlair hennessyLouis pascarellaGwendolyn nieblerInnocoll biotherapeutics holdingDrug administrationInnocoll pharmaceuticalsDose cohort experienced less painGenerally well toleratedAdverse event profile comparableCurrent prescribingPharmaceuticals limitedGurnet point capitalInnocoll presidentChief executive

Innocoll Biotherapeutics plc: Innocoll Announces Successful Completion of Debt Refinancing

$125 million refinancing substantially improves Innocoll's liquidity, enabling further investment in pharmaceutical technology portfolio and growth plan Innocoll Biotherapeutics plc, a specialty pharmaceutical

United kingdomInnocoll biotherapeuticsKostenloser wertpapierhandelBlair hennessyLouis pascarellaAman kumarInnocoll holdingsLife sciences lending at oaktreeDrug administrationInnocoll pharmaceuticalsGurnet point capitalOaktree capital managementChief executive officerCo portfolio managerLife sciences lendingInnocoll holdings limited

Innocoll Announces Successful Completion of Debt Refinancing

Press release content from Business Wire. The AP news staff was not involved in its creation.

United kingdomInnocoll biotherapeuticsBlair hennessyLouis pascarellaAman kumarInnocoll holdingsLife sciences lending at oaktreeDrug administrationInnocoll pharmaceuticalsGurnet point capitalOaktree capital managementChief executive officerCo portfolio managerLife sciences lendingInnocoll holdings limitedInnocoll pharmaceuticals limited

DURECT and Innocoll Announce a $136 Million U S Licensing Agreement for POSIMIR® (Bupivacaine Solution)

/PRNewswire/ DURECT Corporation (Nasdaq: DRRX) today announced a licensing agreement granting Innocoll Biotherapeutics plc, a specialty pharmaceutical.

United statesInnocoll biotherapeuticsLouis pascarellaJamese brownDrug administrationInnocoll pharmaceuticalsExchange commissionInnocoll holdingsInnocoll pharmaceuticals ltdCorporation nasdaqGurnet point capitalChief executive officerInnocoll holdings limitedInnocoll pharmaceuticals limitedGurnet pointPrescribing information

vimarsana © 2020. All Rights Reserved.